|
采购主题 |
[其他买家] 买家信息更新中 |
| 采购内容 |
标题: 买家信息更新中1、委内瑞拉客商欲进口胃和泌尿系统内窥镜> 公司：Endomedica, C.A.> 电话： 0058-212-2578833 > 传真： 0058-212-2577575 > 手机： 0058-414-1334393 > 邮箱：<A href="mailto:endomedica@endomedica.com.ve endomedica@endomedica.com.ve> 地址：Av.Milan,Zona Industrial los Ruices Sur Edif.Mejor Piso 1, Ofic.1-A Caracas,Venezuela Z.P.1071 联系人：Pablo Rivera 经营范围：胃肠病、泌尿、心脏、创伤等各种医疗设备销售和服务 。> 意向：该公司有丰富的购货经验并有资金实力，欲进口检查胃和泌尿系统的内窥镜，寻求合作伙伴。2、巴西客商求购中国铁轨>巴西公司名称: Fercortec Ltda有限公司 电话: 0055-21- 2590-8005 联系人：Jandir de abreu（E-mail：<A href="mailto:abreujandir@yahoo.com.br abreujandir@yahoo.com.br）>3、利比里亚客商欲与中国投资者合作开展木薯加工业>日前，旅居美国的利比里亚籍客商HENRY K. ADDY先生来我处表示，美国有大量的黑人社区，木薯产品在美国有巨大市场，他计划在非洲投资开办木薯产品加工厂，并将产品主要返销其在美国经营的非洲市场。该客商称目前已经在利大巴萨州找到建厂用地并拟定了可行性报告，希望有中国投资者出资金和技术设备，与其合作开展木薯加工业。 > 客商联系方式： > 电话： 001－763－560－2263 （美国） > 00231－6－408792 （利比里亚） 电子邮箱：<A href="mailto:HKWA@AOV.COM HKWA@AOV.COM > 网址:WWW.AFRICAFOODMALL.COM 地址： > 5736 Lakeland Ave North, Crystal,Minnestota,U.S.A>4、白俄罗斯企业寻找中国合作伙伴 该企业(Elmatron)主要加工生产日光灯电阻、应急电源电阻、应急灯控制电阻、各种节能灯。希望与中国生产同类产品的厂家合作。有意合作的中国企业可与其直接联系，了解详情。 > > 联系方式： > Tel./Fax: +375 (17) 212-70-00；+375 (17) 212-11-40；+375 (17) 212-21-54 > E-mail: <A href="mailto:info@elmatron.com info@elmatron.com；<A href="mailto:Kirill_Voytik@elmatron.com Kirill_Voytik@elmatron.com 联系人：Voytik Kirill > 语 言：俄语或英语 >5、爱沙尼亚医药公司寻求投资合作> 爱医药公司Vitale-XD Ltd希望向中国医药企业出售股份，建立合资企业，共同开发爱沙尼亚、欧盟及独联体国家市场。 爱公司名称：Vitale-XD Ltd 电话： 00372-6546922 传真： 00372-6546921 > <A href="mailto:vitale@infonet.ee vitale@infonet.ee > www.vitale.ee 附：Vitale-XD Ltd公司情况 >>The manufacturing of effervescent tablets >>Our objectives >The effervescent tablets manufacturing is a modern project, which has been started in Estonia for the first time. The manufacturing is designed from the cycle beginning and is based on Hoffmann-La Roche’s formulas and technology. Rooms and equipment available >>The project started off from manufacturing multivitamins in the beginning of 2001. The rooms were rented from a Technopol for the drug manufacturing purpose. These rooms were then reconstructed to suit the required manufacturing conditions for a pharmaceutical industry. >>For tableting we use the new FETTE 1200PC tabletpress, which has maximum operation speed of 130000 tablets/hour. >>Licenses and marketing authorizations for drugs >>We are licensed by the Estonian State Agency of Medicines (the activity license valid until October 01, 2013). The manufacturing has been authorized with the following national legislation: >Medicinal Products Act, enforced on April 1, 1996, Art 6 section 1. The manufacturing has been inspected by the supervisory authority-State Agency of Medicines of Estonia and has GMP Certificate. During the project existing time about 0,7 million EUR has been invested into GMP implementation. The following products are being produced now: >1. Pexvital, Apovit (multivitamins), 2. Asprovit C (400 mg acetylsalicylic acid and 300 mg ascorbic acid containing drug), >3. Asprovit (500 mg acetylsalicylic acid containing drug) >4. Paracetamol DM (300 mg paracetamol and 7,5 mg dextromethorphan hydrobromide containing drug), >5. Panivit (500 mg paracetamol and 200 mg ascorbic acid), 6. Aspavit (330 mg acetylsalicylic acid and 200 mg ascorbic acid), >7. Vitamin C (50 mg, 250 mg, 500 mg, 1000 mg) >8. 10 formulations of vitamins+minerals, UK sub-contracting 9. SportActive, vitamins+minerals, Sweden, USA 10. Bath tablets, Germany sub-contracting >11. Aspinat (500 mg acetylsalicylic acid), Aspinat C (400 mg acetylsalicylic acid and 240 mg ascorbic acid containing drug), Aspinat Alko (324 mg acetylsalicylic acid and 80 mg succinic acid), Aspinat Complex (500 mg acetylsalicylic acid, 15 mg phenylephrine, 5 mg pheniramine maleate), Russia sub-contracting., 1,5 mln pakendit >12. Antigrippin-ORVI (500 mg paracetamol, 100 mg ascorbic acid, 10 mg phenylephrine hydrochloride)-ValentaPharm, Russia, 1,5 mln pakendit, .a. 13. ACC-acetylcysteine, 200 mg, 600 mg, ZAO Vertex, St.-Peterburg, 600 tuh.pakendit 14. BioMax, vitamins+minerals, ValentaPharm, Russia, 1 mln pakendit . a. >All of the above listed medicines have marketing authorisations in Estonia, Russia, Republic of Belarus, Ukraine, Georgia, Kazakhstan and Azerbaijan. Personnel >>The staff members have high qualifications, which is required for a pharmaceutical industry. The top managers are experienced to work in the domestic market and in the markets of other countries. The introductive, basic and ongoing training programs are required by the GMP, which are being run for each personnel member. >The future products >We are searching for a strategic business partner for the development of new products and new markets. >Materials in use and suppliers >>All the raw materials, which are in use by us are pharmaceutical grade chemicals. The approved suppliers of the drug ingredients meet the GMP requirements and marketing authorisations. For example, the active substances for multivitamins are supplied as a ready premix by DSM Nutritional. Here are some names of other suppliers of active substances: Dolder AG and Plantaria AG, Switzerland, Rhodia, France, Algol Chemicals Finland, Suzhou Fine Chemicals CO, Shijiazhuang Pharma, Zhejiang Kangle Pharmaceutical CO, etc. >Each ingredient batch is tested before releasing into production in our quality control laboratory. Additonal information >This project is unique due to the fact that all drugs are not subjects of medicinal prescription and are used by a wide consumer groups. >There is a lot of potential in our company and this potential can be seen in the development and production of new products. In order to get income from the production of new products, we are seeking for a strategic business partner, who will deal with the marketing and selling of these products. >>Best regards >Raissa Shushuyeva >Chairman of the Board
|
| |
|
|
|
